Zamzam, Abdelrahman
Syed, Muzammil H.
Harlock, John
Eikelboom, John
Singh, Krishna K.
Abdin, Rawand
Qadura, Mohammad
Funding for this research was provided by:
Blair Foundation
Article History
Received: 15 December 2020
Accepted: 10 May 2021
First Online: 26 May 2021
Competing interests
: Dr. John Eikelboom reports consulting fees/honoraria and/or grant support from Astra-Zeneca, Bayer Boehringer-Ingelheim, Bristol-Myer-Squibb/Pfizer, Daiichi-Sankyo, Eli-Lilly, Glaxo-Smith-Kline, Pfizer, Janssen, Sanofi-Aventis, Servier. The funders also had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. All other authors declare no competing interests.